Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.78 | 36.52 | -73.23% | 9.28 | +5.3% |
| P/S |
|
0.3696 | 7.13 | -94.82% |
|
|
| P/BV |
|
0.7339 | 3.65 | -79.92% |
|
|
| P/FCF |
|
22.49 | 0.253 | 8788.54% |
|
|
| Ev/Ebitda |
|
7.92 | 2.91 | 172.36% |
|
|
| Ev/S |
|
0.5889 | 16.43 | -96.42% |
|
|
| Ev/FCF |
|
19.08 | -1.58 | -1306.77% |
|
|
| E/P |
|
0.0545 | 0.0333 | 63.48% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
3/10
|
8.29 | -9.78 | -184.82% | 7.92 | +4.7% |
| ROE |
|
8.01 | 4.47 | 79% |
|
|
| ROA |
|
3.54 | 3 | 18.06% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
3.78 | -11.06 | -134.17% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.92 | 0.7586 | 152.8% | 2 | -3.9% |
| Nеt Debt/Ebitda |
|
-1.02 | 0.0296 | -3547.72% |
|
|
| Debt/Ratio |
|
0.146 | 0.1204 | 21.32% |
|
|
| Debt/Equity |
|
1.16 | 0.6971 | 66.8% |
|
|
| Debt/Net Income |
|
4.21 | 1.5 | 179.77% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.55/10
|
3.82 | 5.74 | -33.4% | 3.95 | -3.28% |
| Number of years of dividend growth |
|
7 | 1.23 | 469.49% | ||
| DSI |
|
1 | 0.5838 | 71.29% |
|
|
| Average dividend growth |
|
14.29 | 3.99 | 258.05% |
|
|
| Average percentage for 5 years |
|
3.95 | 4.99 | -20.88% |
|
|
| Average percentage for payments |
|
40.31 | 25.09 | 60.65% |
|
|
| Difference from average difference in sector |
|
-1.92 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
21.6 | -10.8 | -300% | ||
| Growth impulse Ebitda in 5 years |
|
55.49 | -43.85 | -226.55% | ||
| Growth impulse Net Income in 5 years |
|
-2.74 | 147.44 | -101.86% | ||
| Growth impulse FCF in 5 years |
|
-894.42 | 10.26 | -8817.54% | ||
| Growth impulse EPS in 5 years |
|
-3.11 | -241.16 | -98.71% |
IP Score
5.55/10
